These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16218201)

  • 1. Managing compliance in production-insights and comparisons in chemical-pharmaceutical companies.
    Rank F; Scheuermann HJ; Wozniewski T; Müller RH
    PDA J Pharm Sci Technol; 2005; 59(4):233-9. PubMed ID: 16218201
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality management benchmarking: FDA compliance in pharmaceutical industry.
    Jochem R; Landgraf K
    Int J Health Care Qual Assur; 2010; 23(8):690-8. PubMed ID: 21125964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-process testing and limits.
    Sjöholm I
    Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA's reaction to corporate compliance audits.
    Shroff AP
    Food Drug Law J; 1996; 51(2):221-3. PubMed ID: 11820199
    [No Abstract]   [Full Text] [Related]  

  • 5. Schering-Plough agrees to pay FDA $500 million and bring factories into compliance.
    Kuehn BM
    J Am Vet Med Assoc; 2002 Jul; 221(2):174, 180. PubMed ID: 12118571
    [No Abstract]   [Full Text] [Related]  

  • 6. A risk-based approach to scheduling audits.
    Rönninger S; Holmes M
    PDA J Pharm Sci Technol; 2009; 63(6):575-88. PubMed ID: 20169864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Accession to the PIC/S and pharmaceutical quality system in Japan].
    Katori N
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):22-35. PubMed ID: 25707200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. As Genzyme flounders, competitors and activist investors swoop in.
    Allison M
    Nat Biotechnol; 2010 Jan; 28(1):3-4. PubMed ID: 20062016
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmaceutical product quality control and good manufacturing practices].
    Hiyama Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician interaction with pharmaceutical companies: the rules are getting tougher.
    Loomis CH
    J Okla State Med Assoc; 2003 Jun; 96(6):278-9. PubMed ID: 12858819
    [No Abstract]   [Full Text] [Related]  

  • 11. Real compliance and how to achieve it.
    Madsen RE
    PDA J Pharm Sci Technol; 2001; 55(2):59-64. PubMed ID: 11310321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practices of excellent companies in the drug industry.
    Pringle F; Kleiner BH
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 1997; 10(1):31-4. PubMed ID: 10166024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey of physician-industry relationships.
    Grande D
    N Engl J Med; 2007 Aug; 357(5):507-8; author reply 508. PubMed ID: 17674458
    [No Abstract]   [Full Text] [Related]  

  • 14. Disease management. Getting out from under drug companies' shadows.
    Heimoff S
    Manag Care; 2000 Mar; 9(3):39-40, 42-3. PubMed ID: 11066212
    [No Abstract]   [Full Text] [Related]  

  • 15. Precipitating factors for pharmaceutical firms.
    McCarthy R
    State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
    [No Abstract]   [Full Text] [Related]  

  • 16. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 17. A risk-based auditing process for pharmaceutical manufacturers.
    Vargo S; Dana B; Rangavajhula V; Rönninger S
    PDA J Pharm Sci Technol; 2014; 68(2):104-12. PubMed ID: 24668599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.